Catalent Inc.
Sector: Manufacturing
Industry: Pharmaceutical Products
63.48
0
(0%)
Volume:
13,882,060
52 week range:
41.15 - 63.50
Market Cap:
11.522B
Company Description:
Catalent, Inc. develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products. It operates through four segments: Biologics and Softgel and Oral Technologies, Oral and Specialty Delivery, and Clinical Supply Services. The company serves pharmaceutical, biotechnology, consumer health companies; and companies in other healthcare market segments such as animal health and medical devices.